SSD rifaximin showed a trend toward reducing the risk of death, but the results were still based on the results of a single study, and more evidence is needed to confirm it (Additional file 3 ).
← all excerpts
Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis
1
—
—